RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy-Reference-Cited by-同舟云学术

RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy

Published:2007-09-13 Issue:5 Volume:122 Page:515-523
ISSN:0340-6717
Container-title:Human Genetics
language:en
Short-container-title:Hum Genet

Author:

Kaufman Beth D.,Auerbach Scott,Reddy Sushma,Manlhiot Cedric,Deng Liyong,Prakash Ashwin,Printz Beth F.,Gruber Dorota,Papavassiliou Dimitrios P.,Hsu Daphne T.,Sehnert Amy J.,Chung Wendy K.,Mital Seema

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics

Link

http://link.springer.com/content/pdf/10.1007/s00439-007-0429-9.pdf

Reference27 articles.

1. Ackerman M (2005) Genetic testing for risk stratification in hypertrophic cardiomyopathy and long QT syndrome: fact or fiction? Curr Opin Cardiol 20:175–181

2. Chai W, Danser A (2006) Why are mineralocorticoid receptor antagonists cardioprotective? Naunyn Schmiedebergs Arch Pharmacol 374:153–162

3. Colan SD, Lipshultz SE, Lowe AM, Sleeper LA, Messere J, Cox GF, Lurie PR, Orav EJ, Towbin JA (2007) Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the pediatric cardiomyopathy registry. Circulation 115(6):773–781

4. Diet F, Graf C, Mahnke N, Wassmer G, Predel HG, Palma-Hohmann I, Rost R, Bohm M (2001) ACE and angiotensinogen gene genotypes and left ventricular mass in athletes. Eur J Clin Invest 31:836–842

5. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ (2000) Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36(7):2212–2218

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Percutaneous cutting balloon angioplasty for the treatment of renovascular hypertension in children and adolescents;Journal of Hypertension;2022-08-18

2. Effect of rs4646994 polymorphism of angiotensin-converting enzyme on the risk of nonischemic cardiomyopathy;Bioscience Reports;2021-12

3. JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies;Circulation Journal;2021-08-25

4. Newer risk assessment strategies in hypertrophic cardiomyopathy;Current Opinion in Cardiology;2020-10-10

5. Aldosterone Synthase Gene (CYP11B2) Polymorphisms and Enhanced Cardiovascular Risk;The Recent Topics in Genetic Polymorphisms;2020-05-13